The Global Molecular Diagnostics Point of Care Market is expected to reach USD 4.84 billion by 2027, registering a CAGR of 10.6%, according to a recent report by Emergen Research. The major elements anticipated to bolster the potential of POC diagnostics market is the extensive research and development to miniaturize tests with molecular diagnostics to enable increased high precision and quick patient testing.
Demand for these tools is anticipated to increase in CLIA tests. Numerous international bodies such as the government are increasingly providing financial support to expand the research and development activities. Additionally, a wide range of point-of-care testing technologies has emerged over the last decade to strengthen its potential in medical faculties with a primary focus on screening, monitoring, and diagnosing infectious diseases in developing economies.
Recent developments in microfluids and genetic sequencing equipment have led the way for the development of cost-effective, precise, and rapid testing platforms that can be utilized as POC systems, thereby augmenting the market’s potential.
Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@ https://www.emergenresearch.com/request-sample-form/11
Top Companies in Prefilled Syringes Market are:
BioMerieux, Abbott Laboratories, Roche Diagnostics, Bio-Rad Laboratories, Bayer Healthcare, Nipro Diagnostics, Danaher Corporation, Abaxis Inc., Dako, and OraSure Technologies Inc., among others.
Prefilled Syringes Market Drivers During Forecast Period:
By Test Location Outlook Segment:
Point-of-care Molecular Diagnostics products are used in majority places for the screening of infectious diseases as they offer the physicians a way to improve the quality of care by providing quick diagnosis and treatment approaches.
Test Location Outlook (Volume, Million Tons; Revenue, USD Billion; 2017-2027)
- Over-the-Counter (OTC)
By Technology Outlook Segment:
PCR-based POC studies is a major contributor to the revenue of the overall market. This can be attributed to the widespread use of PCR-based technology for PCR products in molecular diagnosis. Commercialization of POC tests that deliver rapid real-time PCR analysis with high precision is expected to contribute to the market growth substantially.
ORDER NOW (Customized Report Delivered as per Your Specific Requirement)@ https://www.emergenresearch.com/select-license/11
Technology Outlook (Volume, Million Tons; Revenue, USD Billion; 2017-2027)
- Genetic Sequencing-based
Application Outlook (Volume, Million Tons; Revenue, USD Billion; 2017-2027)
- Prenatal Testing
- Infectious Diseases
End-Use Outlook (Volume, Million Tons; Revenue, USD Billion; 2017-2027)
- Decentralized Labs
- Assisted Living Healthcare Facilities
By Regional Outlook Segment:
- North America accounted for a considerable share of the industry and is expected to show lucrative growth over the forecast years due to the ever-growing incidences of infectious diseases, increasing approvals for CLIA products, and favorable policy implementations.
- Europe is projected to follow North America and the growth of the region can be accredited to the rising demand for rapid diagnosis and the development of novel molecular diagnostic tests for DNA analysis. The Asia Pacific is predicted to be the fastest-growing region in the projected period owing to the increasing population requiring clinical testing and availability of cost-effective PoC molecular tests.
To identify the key trends in the industry and read full summary click on the link: https://www.emergenresearch.com/industry-report/molecular-diagnostics-point-of-care-market
Regional Outlook (Volume, Million Tons; Revenue, USD Billion; 2017-2027)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- Rest of MEA
Insights into our Other Published Healthcare Reports:
Pharmacovigilance Market Size Worth USD 12.48 Billion by 2027 | CAGR of 12.5%
Radiation Dose Management Market to Reach USD 505.3 Million By 2027 | CAGR of 12.6%
Cell Culture Market Size Worth USD 45.12 Billion By 2027 | CAGR of 10.3%
Gene Editing Market Size Worth USD 15.79 Billion By 2027 | CAGR of 17.2%
Joint Reconstruction Devices Market Size Worth USD 36.81 Billion By 2027 | CAGR of 6.3%
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756